presents

Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test

Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…

5 days ago

RMZ Foundation presents Mouna Rebeiz’s artwork at Art Mumbai

Art Mumbai at Mahalaxmi Racecourse is scheduled to open from November 14th to 17th, 2024 MUMBAI, India, Nov. 14, 2024…

1 week ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

1 week ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

1 week ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

1 week ago

Automobili Lamborghini presents the Revuelto Opera Unica at Esperienza Arte in Shanghai

Handcrafted artwork showcases the limitless possibilities of Lamborghini’s Ad Personam customization programShanghai, 10 November 2024 – Automobili Lamborghini unveiled the…

2 weeks ago

Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024)

November 09, 2024 13:00 ET | Source: Replimune Group Inc Oral presentation highlighting IGNYTE primary analysis data shows anti-tumor activity…

2 weeks ago

Ultragenyx Presents Positive Update on GTX-102 Angelman Syndrome Program at FASTs 17th Annual Global Science Summit

November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…

2 weeks ago

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and…

2 weeks ago

Medicenna Presents Preclinical Data from its Anti-PD1-IL-2 BiSKIT and IL-2 Super Agonist Programs at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

November 08, 2024 10:00 ET | Source: Medicenna Therapeutics Corp.    MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” BiSKIT…

2 weeks ago